baber/WOPTO huggingface dataset:
Patent NZ-285793-A (NZ)
Title: Protocol and mechanism for transfer of files between two computers
Inventor: MCWILLIAMS GAVIN
IPC: H04L29/08
Filed: 1995-05-19
Abstract: In order to transfer a series of data files between two computers, each computer is provided with a file transfer mechanism. The file transfer mechanism is responsible for the overall control of the transfer of the series of files. Each file transfer mechanism controls the transfer of a series of files in accordance with a protocol. In this protocol, the computer receiving data files (the initiator) sends a poll request message to the computer transmitting the data files (the responder). In response, the responder sends a reply message to the initiator containing a list of files which are available for transfer. From this list, the initiator selects the files which it wishes to receive and then copies each file in turn. It then sends an acknowledge to the responder.
Patent NZ-312907-A (NZ)
Title: Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl
Inventor: BRIGGS CHRISTOPHER A
IPC: C07D/
Filed: 1996-07-08
Abstract: The specification describes crystalline [R-(R*,R*)]-2-(4-fluorophenyl)- beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4 [(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form I.  The compound also known as atorvastatin is characterized by its X-ray powder diffraction and/or solid state NMR.  Also described are methods for the preparation and pharmaceutical composition of the same.  The compounds are useful as agents for treating hyperlipidemia and hypercholesterolemia.
Patent NZ-335345-A (NZ)
Title: Fluquinconazole as a fungicide against basidomycete and sapstain fungi in the treatment of wood
Inventor: MYLES-GARDINER SHELLEY
IPC: B27K3/34
Filed: 1999-04-22
Abstract: Use of fluquinconazole, 3-(2,4-dichlorophenyl)-6-fluoro-2-(1H-1,2,4-triazol-1-yl)-4(3H)-quinazolinone for combating wood damaging fungi, in particular basidomycete and sapstain fungi.  Organisms also controlled by fluquinconazole include Coriolus versicolor, Poria placenta, Lentinus lepideus, Trametes versicolor, Serpula lacrymans, Coniophora puteana and Gloeophyllum trabeum.  Also described is a fungicidal composition comprising a mixture of fluquinconazole and/or tebuconazole, dichlone, carbendazim, prochloraz, sipconazole, cyproconazole and a phosphonate compound.  Fluquinconazole is used at a concentration of 0.001 to 10% by weight, and the ratio of fluquinconazole to phosphonate is from 5:1 to 1:1.
Patent NZ-335564-A (NZ)
Title: Multicomponent coextruded dental floss embeded in and surround by a single component sheath
Inventor: CHIANG CASPER W
IPC: A61Q11/00
Filed: 1997-11-05
Abstract: Provided is a multicomponent, coextruded monofilament dental floss (Figure 5) comprising a plurality of cores, each core comprising a first material, wherein the plurality of cores are completely embedded in and substantially surrounded by a single sheath comprising a second material and having a continuous surface.  Preferably the sheath comprises an interior portion comprising the second material in which the cores are embedded, and the outer portion comprising a surface material, the outer portion providing the outer surface of the floss (see Figure 5e).
Patent NZ-335849-A (NZ)
Title: Multicomponent fiber comprising two different poly(lactic acid) polymers which provide biodegradable properties
Inventor: TSAI FU-JYA
IPC: D01G19/20
Filed: 1997-11-25
Abstract: multicomponent fibre comprises a first component having a melting temperature and comprising a first poly(lactic acid) polymer with a L:D ratio.  The first component forms an exposed surface on at least a portion of the multicomponent fibre.  A second component of the fibre has a melting temperature that is at least about 10oC greater than the melting temperature exhibited by the first component and comprises a second poly(lactic acid) polymer with an L:D ratio that is greater than the L:D ratio exhibited by the first poly(lactic acid) polymer.  The multicomponent fibre comprises two different polymers which provide biodegradable properties to the fibre.  The multicomponent fibre is useful in making nonwoven structures that may be used in a disposable absorbent product.
Patent NZ-338016-A (NZ)
Title: Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
Inventor: CHABRIER DE LASSAUNIERE PIERRE
IPC: C07D311/24
Filed: 1998-02-16
Abstract: he invention concerns novel 2-(iminomethyl)amino-phenyl derivatives, their preparation, their application as medicines and pharmaceutical compositions containing them. 2-(iminomethyl)amino-phenyl derivatives seem to have an inhibitory activity on NO-synthase enzymes producing nitrogen monoxide NO and/or an activity which traps the reactive oxygen species (ROS). Given the potential role of NO and ROS's in physiopathology, the new derivatives described corresponding to general formula (I) may produce beneficial or favourable effects in the treatment of pathologies where these chemical species are involved. In particular cardio and cerebro-vascular disorders, disorders of the central or peripheral nervous systems, disorders of the skeletal muscle and neuromuscular joints, proliferative and inflammatory diseases, organ transplant, autoimmune and viral diseases, cancer, neurological diseases associated with intoxications and all pathologies characterised by an excessive production or dysfunction of NO and/or ROS's. The compounds of the invention correspond to general formula (I) A represents either formula (II) or a radical in which R1 and R2 represent, independently, a hydrogen, a halogen, the OH group, a linear or branched alkyl or alkoxy radical having from 1-6 carbon atoms. R3 represents a hydrogen atom, a linear or alkyl branched radical having from 1 to 6 carbon atoms or a -COR4 radical, R4 represents a linear or branched alkyl radical having from 1 to 6 carbon atoms or A represents formula (III)  or A represents formula (IV), wherein R5 represents a hydrogen atom, the OH group or a linear or branched alkyl or alkoxy radical having from 1-6 carbon atoms  B represents a linear or branched alkyl radical having from 1-6 carbon atoms, carbocyclic or heterocyclic aryl with 5 or 6 members containing from 1-4 heteroatoms chosen from O,S, N and in particular the thiopene, furan, pyrrole or thiazole radicals, the aryl radical being optionally substituted by one or more groups chosen from the linear or branched alkyl, alkenyl or alkoxy radicals having from 1-6 carbon atoms  X  represents -Z1-, -Z1-CO-, CH+CH-CO, -Z1-NR3-CO-, -Z1-NR3CS-, -Z1-NR3SO2- or a single bond  Y represents a radical chosen from -Z2-Q, piperazine, homopiperazine, 2-methylpiperazine, 2,5 dimethyl-piperazine, 4-aminopiperidine, -NR3-Z2-Q-, -NR3-CO-Z2-Q-, -NR3-NH-CO-Z2-Q-, -NH-NH-Z2-, -NR3-O-Z2-, -NR3-SO3-NR3-Z2-, -O-Z2-Q-, -O-CO-Z2-Q- or -S-Z2-Q- radicals  In which Q represents a single bond, O-Z3, R3-N-Z3 or S-Z3  Z1, Z2 and Z3 represents independently a single bond or linear or branched alkylene radical having from 1-6 carbon atoms; preferably, Z1, Z2 and Z3 represent- (CH2)m-, m being an integer between 0-6.
Patent NZ-502210-A (NZ)
Title: Pyridine derivatives
Inventor: HECKENDORN ROLAND
IPC: A61P25/00
Filed: 1998-07-09
Abstract: Compounds of formula (I), pharmaceutical compositions containing compounds of formula (I), and the use of these compounds of for modulating the activity of mGluRs and for treating mGluR5 mediated diseases, including epilepsy and ischemias.
Patent NZ-503005-A (NZ)
Title: Member for receiving a side of a sashless window and having arms with grooves to receive a portion of a sealing member
Inventor: LANGNER ROBERT CHARLES
IPC: E06B3/54
Filed: 2000-02-24
Abstract: Disclosed is/are a pane receiving members 21,31 for fitting to sides of one, or as shown two, window panes 1,2 which each have a pair of arms 23,33 which each have a groove to receive a portion of a sealing strip.
Patent NZ-503491-A (NZ)
Title: 2-substituted amino-1,3-benzothiazole derivatives useful as protein tyrosine kinase inhibitors
Inventor: DAS JAGABANDHU
IPC: A61K31/454
Filed: 1998-11-02
Abstract: A benzothiazole compound of formula I or a salt thereof where p is 0,1, 2 or 3; X1 and X2 are each hydrogen, or together form =O or =S; each R1 is independently hydrogen, R6, -OH, -OR6, -SH, -SR6, -C(O)qH, -C(O)qR6, -O-C(O)qR6, -S(O)qR6; halo; cyano; nitro; -Z4-NR7R8; -Z4-N(R9)-Z5-NR10OR11; -Z4-N(R12)-Z5-R6; -SO3H, -P(O)(OR6)2; or any two groups R1 may together with the carbon atoms to which they are attached form a 3-to 8-membered optionally saturated optionally substituted ring, R2 and R3 are each independently hydrogen or R6; -Z4-R6 or -Z13-NR7R8; R4 and R5 are each independently hydrogen or R6 or together with the nitrogen atom to which they are attached form a 3-to 8-membered optionally saturated optionally substituted heterocyclic ring which heterocyclic ring which may be fused to an optionally substituted benzene ring; q and R6 to R14 are as defined in the specification; Z4 and Z5 are each independently a single bond; -Z11-S(O)q-Z12-; -Z11-C(O)-Z12-; -Z11-C(S)-Z12-; -Z11-O-Z12-; -Z11-S-Z12-; -Z11-O-C(O)-Z12-; or -Z11-C(O)-O-Z12-; Z11 and Z12 are each independently a single bond; alkylene; alkenylene; or alkynylene; Z13 is a single bond; -Z11-S(O)q-Z12-; -Z11-C(O)-Z12-; -Z11-C(S)-Z12-; -Z11-O-Z12-; -Z11-S-Z12-; -Z11-O-C(O)-Z12-; -Z11-C(O)-O-Z12-; -C (NR13)-; -C (CHR14)- ; or -C(C(R14)2)-. This compound can be used for the treatment of protein tyrosine kinase associated disorder.
Patent NZ-506900-A (NZ)
Title: Embedding decorative materials in mouldable material applied to a building block
Inventor: LLOYD MALCOLM WILLIAM SYDNEY S
IPC: E04C1/40
Filed: 2000-09-06
Abstract: A decorative module 1 for enhancing visual properties of structures having a base 3 and multiple elements 4 individually affixed to the base.  The elements have inherent light reflective, refractive or absorptive properties and are configured in accordance with any regular geometric shape 6.  The elements are affixed to the base to effect a multi-planed, multifaceted, 3-dimensional geometric shape.
Patent NZ-508353-A (NZ)
Title: Mammalian fetal insulin-like growth factor II (IGF-II) antisense oligonucleotide sequences and methods to ihibit metastasis of tumor cells
Inventor: WRIGHT JIM A
IPC: A61P35/00
Filed: 1999-04-23
Abstract: Antisense oligonucleotide of less than 100 nucleotides comprising a sequence complementary to at least 7 contiguous nucleotides of a 5'-untranslated region of exons 4, 5 or 6 of a mammalian fetal IGF-II mRNA, which inhibits IGF-II expression, are described. Pharmaceutical composition can contain the oligonucleotide or a vector comprising the oligonucleotide and are useful for inhibiting the growth and metastasis of cancer cells and for treating cancer. In vitro methods and methods of treating non-human animals comprising administrating the oligonucleotide are also described. The oligonucleotide may be used in conjunction with a further chemotherapeutic drug.
Patent NZ-514980-A (NZ)
Title: Quinoline derivatives useful as inhibitors of MEK enzymes
Inventor: BOYLE FRANCIS THOMAS
IPC: C07D413/12
Filed: 2000-05-03
Abstract: A compound or a pharmaceutically acceptable salt thereof has the formula (I) wherein: n is 0 or 1; X and Y are independently -NR-, -O- or -S- and X may additionally comprise a CH2; R7 is (CH2)mR9; m is 0 to 3; R9 is substituted aryl or optionally substituted cycloalkyl or heterocyclic ring or an N-oxide of any nitrogen- containing ring; R is H or alkyl; R6 is optionally substituted divalent cycloalkyl, pyridinyl, pyimidinyl, or phenyl ring; R1 to R4 are independently hydrogen, hydroxy, halogeno, cyano, nitro, trifluoromethyl, alkyl, -NR11R12 or a group R13-X1-(CH2)x; x is 0 to 3; X1 is -O-, -CH2-, -OCO-, carbonyl,-S-,-SO-, -SO2-, -NR14CO-, -CONR15-, -SO2NR16-, -NR17SO2- or -NR18 and R11 to R18 are as defined in the specification.
Patent NZ-517100-A (NZ)
Title: An end seal for a manufactured seed and a method of manufacturing and attaching the same
Inventor: HIRAHARA EDWIN
IPC: A01H4/00
Filed: 2000-08-22
Abstract: A method of attaching an end seal (20) to a manufactured seed (22).  The method includes the steps of positioning a first manufactured seed on a surface (42).  The first manufactured seed includes a seed coat (24) having an opening (12) and an embryo (30) disposed within the opening.  The opening has a location relative to the surface.  The method further includes prestressing an area (38) of a sheet (50) and positioning the sheet on the first manufactured seed to substantially centre the area over the opening, such that the embryo is located below the area.  The method also includes the step of attaching the sheet to the first manufactured seed to seal the opening.
Patent NZ-518244-A (NZ)
Title: Obtaining rapidly dividing somatic cells before cell cycle completion (15 hours or less)
Inventor: ROBL JAMES M
IPC: C12N15/85
Filed: 2000-10-13
Abstract: Described is a method of synchronising a population of somatic cells in G1 for purposes of preparing the cells for nuclear transfer or nuclear transplantation by using mechanical shake-off and selection of mitotic doublet cells. This method may further comprise cooling of the cells or other means of synchronising the cells in G1 phase for longer periods of time. The use of a synchronised population of rapidly, dividing somatic cells obtained by these methods as a source of donor nuclei or chromatin for use in nuclear transfer or nuclear transplantation is described also.
Patent NZ-520033-A (NZ)
Title: Fork body bearing assembly for a shearing handpiece
Inventor: SMALL WAYNE RUSSELL
IPC: B26B19/24
Filed: 2002-07-05
Abstract: A bearing assembly for a shearing handpiece, the handpiece having a pivoting fork body supported on a centre post, the bearing assembly being adapted to be positioned between the fork body and the centre post and comprising: a first contact surface for supporting the fork body, a second surface for mounting on a centre post, a bearing means disposed between the first and second surfaces.
Patent NZ-522414-A (NZ)
Title: Process for the purification of a salt of clavulanic acid
Inventor: ZHANG GUO
IPC: C07D503/00
Filed: 2001-05-09
Abstract: A process for the preparation of a pharmaceutically acceptable metal salt of clavulanic acid comprises washing a salt of a clavulanic acid in a wash medium, or recrystallisation of a salt of clavulanic acid from a recrystallisation medium, or preparation of a salt of clavulanic acid in a preparation medium wherein the wash, medium, recrystallisation medium or the preparation medium is at a pH less than 6.0. Also disclosed is a process for the preparation of potassium clavulanate from crude clavulanic acid wherein an intermediate amine salt prepared from crude clavulanic acid is exposed to a pH less than 6.0 in a liquid medium and the intermediate amine salt is subsequently converted into potassium clavulanate.
Patent NZ-522477-A (NZ)
Title: Improvements in or relating to tube couplings
IPC: F16L37/092
Filed: 2002-11-07
Abstract: A tube coupling to receive and hold a tube comprising a coupling body having a throughway open at one end to receive an end portion of tube, an annular step in the throughway facing the open end to provide an end stop for a tube end, an end cap engaging the coupling body for axial movement between forward and retracted positions on the body, the end cap having an opening for the end portion of the tube to extend therethrough and a tube locking device in the cap to promote entry of a tube into the cap and to resist withdrawal of the cap, an annular step, the seal having a radially inner annular portion with which the tube end is engagable and a radially outer annular portion, and means to compress the outer annular portion of the seal axially in response to forward movement of the end cap to cause the inner portion of the seal to be pressed into sealing engagement with the tube end.
Patent NZ-523334-A (NZ)
Title: Improvements in curtain sides
Inventor: ARENDS PAUL CHRISTOPHER
IPC: B65D90/02
Filed: 2002-12-20
Abstract: Described is a rail system for a curtain side of a vehicle that includes a corner rail assembly which incorporates a track configured to permit roller hangers of the curtain side to move along it. Also described is a rail extension track which cooperates with the corner rail assembly and extends it at an angle to a main track from which a curtain side will be suspended when the curtain side is in a closed position.
Patent NZ-525751-A (NZ)
Title: HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
Inventor: SOERENSEN BIRGER
IPC: G01N33/569
Filed: 2000-03-02
Abstract: Peptides and modified peptides based on conserved regions of a human immunodeficiency virus (HIV) protein capable of inducing an HIV-1 specific immune response without antagonizing the cytotoxic T-cell activity in order to achieve an effective prophylactic and therapeutic vaccine against HIV. Such peptides are useful as vaccines and for detecting antibodies induced by the HIV in a sample. The peptides are based on conserved regions of HIV gag p24 proteins. Antigens in free- or carrier-bound form comprising at least one of the said peptides, vaccine compositions containing at least one of the antigens, immunoassay kits and a method of detecting antibodies induced by HIV or HIV specific peptides using such antigens, are described. (62) Divided out of 514619
Patent NZ-528181-A (NZ)
Title: Glass concrete composite panel
Inventor: LOFTUS ROY
IPC: B28B23/00
Filed: 2002-02-13
Abstract: A construction system and method for constructing a glass or other block panel (51). The construction system involves creating a composite moulding from interlocking moulding modules (15) each of which have a gasket 19 fitted into a groove (39) thereon. The glass blocks (23) are subsequently laid on top of the mouldings (15) with the gaskets (19) forming a seal around the periphery of the planar faces (23b) of the glass blocks (23). The mouldings (15) have outwardly flared circumferential walls (31) from their supporting faces (33) to create interstices (25) between the glass blocks and circumferential walls (33) within which a concrete binder (27) can be poured and reinforcing rods (29) laid to create a composite panel (11). After curing, the mouldings (15) are released from the panel composite (11), together with the gaskets (19) to expose the planar face (23b) of the glass blocks (23) free from incursions of the binder (27) by virtue of the sealing nature of the gaskets (19).A moulding (15) and gasket (19) are also described.
Patent NZ-528925-A (NZ)
Title: Cut resistant paper and paper articles and method for making same
Inventor: WILLIAMS RICHARD C
IPC: D21H21/54
Filed: 2002-04-11
Abstract: The specification discloses a method for making a paper material having a reduced tendency to cut human skin. The Method includes providing a papermaking furnish containing cellulosic fibers and from about 0.5 to about 5.0 wt% by weight dry basis expandable microspheres, forming a paperboard web from the papermaking furnish, drying the web, and calendaring the web to a caliper of from about 18.0 mils and a density ranging from about 7.0 to about 12.0 1b/3000ft2/mil. Papers formed according to the method and articles formed therefrom are also disclosed.
Patent NZ-529438-A (NZ)
Title: Dipeptide derivatives
Inventor: FINK CYNTHIA ANNE
IPC: A61K38/00
Filed: 2002-05-14
Abstract: Dipeptide derivative compounds of the formula (I) are disclosed, wherein R, R1, COOR2, R3 to R7, alk, and X are as defined in the specification. These dipeptide derivatives are useful as dual inhibitors of angiotensin converting enzyme and neutral endopeptidase, as well as inhibitors of endothelin converting enzyme. In a preferred embodiment R and R5 represent hydrogen; R1 represents benzyl; R3 represents hydrogen, acetyl or methoxyacetyl; R4 represents isopropyl or tert-butyl; R6 and R7 represent methyl; X represents -O-; alk represents methylene; and COOR2 represents carboxyl or ethoxycarbonyl.
Patent NZ-533514-A (NZ)
Title: Cleaner head for a vacuum cleaner
Inventor: ROCKE ALEXANDER SIMON DAVID
IPC: A47L9/04
Filed: 2002-11-15
Abstract: A cleaner head 90 for a vacuum cleaner that allows a reduction in the amount of force necessary to move the head backwards or forwards across a surface without first physically moving the head is disclosed. The head includes a suction opening 100 in a face of the head housing which is intended to face a floor surface and a suction passage 110 for the flow of dirt-laden air to an outlet connected to a vacuum cleaner. A bleed air inlet 118 is located in the housing and closed by a bleed valve 124 which is openable to allow air to be bled into the suction passage via the bleed air inlet. The cleaner head further has a force-transmitting member 122 connected to the housing by a connection allowing relative movement between the force-transmitting member and the housing. The bleed valve opens when the amount of force necessary to move the cleaner head exceeds a value selected by appropriate selection of the force transmitting member used. When the bleed valve is opened the cleaner head becomes easier to move as an extra air inlet is provided.
Patent NZ-536963-A (NZ)
Title: Use of the discovery that Fc gamma receptor IIA transgenic animals are susceptible to autoimmune disease, to suppress aberrant immune activity and to treat or prevent autoimmune disease
Inventor: HOGARTH PHILLIP MARK
IPC: C07K14/735
Filed: 2003-06-06
Abstract: A FcgammaRIIa transgenic non-human animal model for autoimmune disease, particularly arthritis. This invention also provides a method of using this model to screen compounds that can reduce aberrant immune activity including aberrant immune complex formation aberrant immune complex clearance and immune complex induced inflammation. This invention also provides means of using this model to treat or prevent autoimmune disease.
Patent NZ-537178-A (NZ)
Title: An installation tool
Inventor: BOWEN PETER EDWARD
IPC: H02G3/22
Filed: 2003-06-13
Abstract: A tool is disclosed for installing an object into a cavity region. The tool includes an identifying means for providing a visual indication of an entry point for lowering the object into the cavity region. The entry point is relative to an opening in the cavity region. The tool also includes a capturing means for capturing the object after the object has been lowered into the cavity region from the entry point so as to allow the object to be retracted through the opening. The tool has a body which carries the identifying means and the capturing means. Part of the body is arranged so as to allow at least the identifying means and the capturing means to be inserted into the cavity region through the opening.
Patent NZ-541833-A (NZ)
Title: Use of calmodulin kinase II inhibitors, mainly SEQ ID NO:4, to treat myocardial dysfunction in structural heart disease
Inventor: ANDERSON MARK
Filed: 2002-10-01
Abstract: Disclosed is an inhibitor of Calmodulin Kinase II (CaMKII) for use in the manufacture of a medicament to treat or prevent ischemic injury to the heart in a subject. The inhibitor comprises the peptide of SEQ ID NO:4.
Patent NZ-555597-A (NZ)
Title: Improvements relating to ovens
Inventor: WILSON GUY EMERSON
Filed: 2005-11-24
Abstract: A home appliance, particularly an oven, that has power link to an electrical load located in a drawer (5) extendable from a cabinet is disclosed. The power link acts as a conduit between a power supply and the load even when the drawer is in an open position. The power link includes a first swivelling connector (35) on the cabinet, a second swivelling connector (37) on the drawer, and a rigid link arm (36) rigidly connected at one end to one of the connectors and slidably connected to the other connector. A wiring harness (34) passes along the length of the link arm and connects the supply to the load.